327 related articles for article (PubMed ID: 30153961)
1. The Cancer Epigenome: Exploiting Its Vulnerabilities for Immunotherapy.
Loo Yau H; Ettayebi I; De Carvalho DD
Trends Cell Biol; 2019 Jan; 29(1):31-43. PubMed ID: 30153961
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets.
Yang J; Xu J; Wang W; Zhang B; Yu X; Shi S
Signal Transduct Target Ther; 2023 May; 8(1):210. PubMed ID: 37217462
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics and immunotherapy: The current state of play.
Dunn J; Rao S
Mol Immunol; 2017 Jul; 87():227-239. PubMed ID: 28511092
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of immune checkpoints: another target for cancer immunotherapy?
Ali MA; Matboli M; Tarek M; Reda M; Kamal KM; Nouh M; Ashry AM; El-Bab AF; Mesalam HA; Shafei AE; Abdel-Rahman O
Immunotherapy; 2017 Jan; 9(1):99-108. PubMed ID: 28000527
[TBL] [Abstract][Full Text] [Related]
5. Understanding the epigenetic regulation of tumours and their microenvironments: opportunities and problems for epigenetic therapy.
Liu M; Zhou J; Chen Z; Cheng AS
J Pathol; 2017 Jan; 241(1):10-24. PubMed ID: 27770445
[TBL] [Abstract][Full Text] [Related]
6. Advances in epigenetic therapeutics with focus on solid tumors.
Jin N; George TL; Otterson GA; Verschraegen C; Wen H; Carbone D; Herman J; Bertino EM; He K
Clin Epigenetics; 2021 Apr; 13(1):83. PubMed ID: 33879235
[TBL] [Abstract][Full Text] [Related]
7. Conserved methylation signatures associate with the tumor immune microenvironment and immunotherapy response.
Qin Q; Zhou Y; Guo J; Chen Q; Tang W; Li Y; You J; Li Q
Genome Med; 2024 Apr; 16(1):47. PubMed ID: 38566132
[TBL] [Abstract][Full Text]
